Latham & Watkins LLP represented the underwriters and placements agents in the transaction.Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, has announced the…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
